Syneos Health Market Research Report
Company Overview
- Name: Syneos Health
- Mission: Syneos Health is committed to translating clinical, medical affairs, and commercial insights into outcomes to address modern market realities. The organization is dedicated to accelerating customer success by deploying advanced technologies and business practices for the delivery of therapies to patients.
- Founded: No information is available regarding the specific founding date or founders.
- Key People:
- Costa Panagos, Chief Executive Officer
- Colin Shannon, Executive Chairman
- Headquarters: Morrisville, North Carolina
- Number of Employees: No information is available.
- Revenue: No information is available regarding the specific revenue details.
- What the Company is Known For: Syneos Health is a leading fully integrated biopharmaceutical solutions organization, providing services across the clinical-to-commercial spectrum. Known for its expertise in therapeutic development, commercialization services, and a commitment to speeding important therapies to market.
Products
- Primary Offerings:
- Oncology: Extensive expertise in oncology and hematology, providing a range of services from preclinical to full commercialization.
- Ophthalmology: Conducted over 290 projects since 2010, known for development and commercialization of 48 approved eye care products.
- Predictive Commercial Solutions: Delivers predictive solutions that reduce risk and accelerate commercial performance through insights into human behavior and market dynamics.
- High-Level Product Descriptions: These services cater to different stages of drug development, incorporating specialized expertise across clinical development, medical affairs, and commercial delivery.
- Key Features:
- Integrated AI and tech-enabled insights for enhanced performance and reduced risk.
- Comprehensive service offerings from drug discovery to patient delivery.
- Deep understanding of therapeutic areas, enabling precise service delivery tailored to specific market needs.
Recent Developments
- Recent Appointments:
- Costa Panagos was appointed as CEO on October 9, 2024.
- He has a strong background in CROs and previously served as President, Research & Development Solutions at IQVIA.
- Recognition:
- Six colleagues were awarded the 10th Annual PM360 ELITE 100 Awards for significant contributions to biopharmaceutical industry, showcasing the company’s strong leadership and expertise within the industry.
- Key Insights and Innovations:
- Partnered in AI models for Alzheimer’s patient screening predictions, enhancing trial efficiency.
- Engaged in innovative genetic medicine initiatives emphasizing patient-focused care.
- Partnerships and Acquisitions:
- Completed acquisition by affiliates of Elliott Investment Management L.P., Patient Square Capital, and Veritas Capital as of September 2023.
- Industry Engagement:
- Executive participation in industry events like FT Live, emphasizing strategic partnerships in biotech innovations.
By integrating technologies and nurturing a diverse culture, Syneos Health continues to be a pivotal player in the biopharmaceutical sector, advancing medical treatments and supporting the dynamic evolution of healthcare solutions across the globe. This concise summary is based on available data and articulates Syneos Health’s core competencies, leadership endeavors, and strategic industry advancements.
